Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 25, 2026

Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells
12:54

Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells

Published on: May 19, 2023

2.6K

A simple in vitro method for evaluating dendritic cell-based vaccinations.

Phuc Van Pham1, Nhung Thi Nguyen1, Hoang Minh Nguyen1

  • 1Laboratory of Stem Cell Research and Application, University of Science, Vietnam National University, Ho Chi Minh City, Vietnam.

Oncotargets and Therapy
|August 30, 2014
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular and phenotypic characterization of SG9R-like <i>Salmonella</i> Gallinarum field isolates from South Korea, 2019-2025.

Frontiers in veterinary science·2026
Same author

What is the diagnostic accuracy of contrast enema for Hirschsprung disease during COVID-19 service disruption in Vietnam? A retrospective study.

BMJ open·2026
Same author

The role of 316 SS surface finishes in enhancing corrosion protection of conducting polyaniline coatings.

RSC advances·2026
Same author

Establishment of a BALB/c Mouse Model for Photoaged Skin: Insights into UV-Induced Dermatological Changes.

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)·2026
Same author

Assessment of peak bone mineral density and its associated factors in Vietnamese adults: A cross-sectional study.

PloS one·2026
Same author

Osteogenic potential of tamarind seed polysaccharide sulfate in tissue engineering.

Biomedical materials (Bristol, England)·2026
Same journal

ELOVL6 Promotes the Proliferation and Migration of Oral Squamous Cell Carcinoma Cells Through Fatty Acid Remodelling and ROS Modulation in vitro.

OncoTargets and therapy·2026
Same journal

<i>NR5A2</i> Promotes Cell Growth and Resistance to Temozolomide Through Regulating Notch Signal Pathway in Glioma [Retraction].

OncoTargets and therapy·2026
Same journal

Primary Hepatic Epithelioid Gastrointestinal Stromal Tumor: A Rare Case.

OncoTargets and therapy·2026
Same journal

MiR-153-3p Suppresses Cell Proliferation, Invasion and Glycolysis of Thyroid Cancer Through Inhibiting E3F3 Expression [Retraction].

OncoTargets and therapy·2026
Same journal

lncRNA CASC9 Regulates Cell Migration and Invasion in Hemangioma Endothelial Cells by Targeting miR-125a-3p/Nrg1 [Retraction].

OncoTargets and therapy·2026
Same journal

MFAP2 Promotes Epithelial-Mesenchymal Transition in Gastric Cancer Cells by Activating TGF-β/SMAD2/3 Signaling Pathway [Retraction].

OncoTargets and therapy·2026
See all related articles

This study developed an in vitro assay using impedance-based cell analysis to evaluate dendritic cell (DC) therapy efficacy against breast cancer stem cells (BCSCs). The assay effectively measured DC and cytotoxic T lymphocyte (CTL) inhibition of BCSCs.

Area of Science:

  • Immunology
  • Cancer Research
  • Cell Biology

Background:

  • Dendritic cell (DC) therapy shows promise for cancer treatment.
  • DCs are increasingly utilized in clinical cancer therapies.
  • A breast cancer model was employed to develop a novel in vitro assay for DC therapy evaluation.

Purpose of the Study:

  • To develop and validate an in vitro assay for assessing dendritic cell (DC) therapy efficacy.
  • To evaluate the inhibitory effects of antigen-primed DCs and cytotoxic T lymphocytes (CTLs) on breast cancer stem cells (BCSCs).
  • To establish a reliable method for measuring DC-mediated anti-cancer activity.

Main Methods:

  • Dendritic cells (DCs) were generated from murine bone marrow cells.
  • Immature DCs were primed with antigens derived from breast cancer stem cells (BCSCs) isolated from 4T1 cell lines.
Keywords:
CTLscytotoxicity assaydendritic cellsimmunotherapytargeting therapy

More Related Videos

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

10.9K
In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
07:05

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

9.2K

Related Experiment Videos

Last Updated: Apr 25, 2026

Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells
12:54

Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells

Published on: May 19, 2023

2.6K
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

10.9K
In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model
07:05

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

9.2K
  • An impedance-based cell analysis system (xCELLigence) was used to assess BCSC proliferation, doubling time, and the inhibitory effects of DCs and CTLs.
  • Main Results:

    • Impedance-based analysis accurately reflected the cytotoxicity and inhibitory effects of DCs and CTLs on BCSCs after 72 hours.
    • Varying ratios of DC to CTL significantly influenced the observed cytotoxicity.
    • The assay demonstrated sensitivity to the combined effects of immune cells on cancer stem cells.

    Conclusions:

    • An impedance-based cell analysis assay was successfully established for evaluating dendritic cell (DC) efficacy in cancer immunotherapy.
    • This novel in vitro method provides a valuable tool for assessing DC-based cancer treatments.
    • The developed assay holds potential for advancing the development and improvement of cancer immunotherapies.